January 08, 2021

Southeast Asia Eyes China’s Sinovac COVID-19 Vaccine-Devex

Brazilian researchers announced Thursday that Sinovac’s new coronavirus vaccine is safe and effective based on the result of phase III clinical trials in the country. That data is being submitted to Anvisa, the country’s regulatory authority, for emergency use application. The much-awaited announcement, which has been delayed multiple times, was released with very few details, which raised some questions. Devex, 01/08/2021